| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |